Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals (AMRX) Stock Price & Analysis


AMRX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.24 - $3.77
Previous Close$2.39
Average Volume (3M)958.69K
Market Cap
Enterprise Value$3.18B
Total Cash (Recent Filing)$151.07M
Total Debt (Recent Filing)$2.73B
Price to Earnings (P/E)-2.7
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.89
Shares Outstanding305,454,163
10 Day Avg. Volume986,673
30 Day Avg. Volume958,689
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)0.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.40
Enterprise Value/Gross Profit4.05
Enterprise Value/Ebitda18.54
Price Target Upside53.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Amneal Pharmaceuticals Inc’s price range in the past 12 months?
Amneal Pharmaceuticals Inc lowest stock price was $1.24 and its highest was $3.77 in the past 12 months.
    What is Amneal Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Amneal Pharmaceuticals Inc’s upcoming earnings report date?
    Amneal Pharmaceuticals Inc’s upcoming earnings report date is Aug 10, 2023 which is in 70 days.
      How were Amneal Pharmaceuticals Inc’s earnings last quarter?
      Amneal Pharmaceuticals Inc released its earnings results on May 05, 2023. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.096 by $0.024.
        Is Amneal Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Amneal Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Amneal Pharmaceuticals Inc pay dividends?
          Amneal Pharmaceuticals Inc does not currently pay dividends.
          What is Amneal Pharmaceuticals Inc’s EPS estimate?
          Amneal Pharmaceuticals Inc’s EPS estimate is $0.11.
            How many shares outstanding does Amneal Pharmaceuticals Inc have?
            Amneal Pharmaceuticals Inc has 153,337,280 shares outstanding.
              What happened to Amneal Pharmaceuticals Inc’s price movement after its last earnings report?
              Amneal Pharmaceuticals Inc reported an EPS of $0.12 in its last earnings report, beating expectations of $0.096. Following the earnings report the stock price went up 4.348%.
                Which hedge fund is a major shareholder of Amneal Pharmaceuticals Inc?
                Among the largest hedge funds holding Amneal Pharmaceuticals Inc’s share is Hussman Strategic Advisors Inc. It holds Amneal Pharmaceuticals Inc’s shares valued at 250K.


                  Amneal Pharmaceuticals Stock Smart Score

                  The Amneal Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Amneal Pharmaceuticals Inc

                  Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.


                  Top 5 ETFs holding AMRX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  iShares Russell 3000 ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity MSCI Health Care Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold AMRX. The ETFs are listed according to market value of AMRX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Teva Pharmaceutical
                  Mallinckrodt public limited company

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis